Lenita Viitanen

Title: Lenita Viitanen: Innovator in Vascular Adhesion Protein Research

Introduction

Lenita Viitanen is a prominent inventor based in Turku, Finland. She has made significant contributions to the field of vascular adhesion proteins, particularly through her innovative research and patenting efforts. Her work focuses on the structural information of crystalline human VAP-1, which has important implications for medical research and drug development.

Latest Patents

Lenita Viitanen holds a patent for her invention titled "Crystalline VAP-1 and uses thereof." This patent relates to crystalline vascular adhesion protein-1 (VAP-1) and outlines methods for utilizing structural information of crystalline human VAP-1 for the identification, design, and production of ligands and inhibitors. The invention also includes screening assays for the detection of these compounds, as well as inhibitors identified through these assays. She has 1 patent to her name.

Career Highlights

Viitanen is associated with Biotie Therapies Corporation, where she has been instrumental in advancing research related to vascular adhesion proteins. Her work has contributed to a deeper understanding of the role of VAP-1 in various biological processes, paving the way for potential therapeutic applications.

Collaborations

Throughout her career, Lenita has collaborated with notable colleagues, including Tiina Annamaria Salminen and Tomi Airenne. These collaborations have enhanced her research efforts and contributed to the success of her projects.

Conclusion

Lenita Viitanen is a key figure in the field of vascular adhesion protein research, with her innovative patent on crystalline VAP-1 showcasing her expertise and dedication. Her contributions continue to influence the landscape of medical research and drug development.